Loading…

Browse All Grants

606,025 grants found

Filters
Reset

Showing 25,52125,540 of 606,025 grants

Active NON-SBIR/STTR RPGS
Substance of Change: Evaluation of Web-Based Training for Mentors and Staff Serving Youth Impacted by Substance Misuse
NATIONAL INSTITUTE ON DRUG ABUSE Innovation Research and Training, Inc United States 2024 – 2027

“Substance of Change: Evaluation of Web-Based Training for Mentors and Staff Serving Youth Impacted by Substance Misuse” Approximately 1.6 million youth between the ages of 12-17-y...

$2.64M
USD
Active NON-SBIR/STTR RPGS
Investigation of active kinome networks in Alzheimer's dementia.
NATIONAL INSTITUTE ON AGING University of Toledo Health Sci Campus United States 2024 – 2029

Summary This is a revised R01 application from a team of established investigators who bring complementary expertise for a multi-omics, hypothesis generating, series of experiments...

$7.88M
USD
Active NON-SBIR/STTR RPGS
Development of Biotherapeutic Nanogels for Alzheimers Disease Treatment
NATIONAL INSTITUTE ON AGING Florida International University United States 2024 – 2026

Development of Biotherapeutic Nanogels for Alzheimer’s Disease Treatment. PROJECT SUMMARY (ABSTRACT): Alzheimer's disease (AD) is a neurodegenerative disease that has affected...

$1.48M
USD
Completed NON-SBIR/STTR RPGS
Telerehabilitation In The Home After Stroke: A Randomized, Controlled, Assessor-Blind Clinical Trial (The TR-2 Trial)
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND S... University of California Los Angeles United States 2024 – 2025

Project SummaryHigh doses of intensive rehabilitation therapy improve functional outcomes after stroke, but most patients do not receive this, for reasons that include limited acce...

$44.09M
USD
Active TRAINING, INDIVIDUAL
Defining the role of mechanotransduction pathways in activating cardiac fibroblasts to cause fibrosis after myocardial infarction.
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE Stanford University United States 2024 – 2027

PROJECT SUMMARY/ABSTRACT Fibrosing cardiac diseases cause 25% of deaths in the United States. Fibrosis is a key pathological hallmark of nearly all cardiac diseases, including hype...

$419.2K
USD
Active NON-SBIR/STTR RPGS
Turning back biological clock: mechanisms of age reversal in a whole organism
NATIONAL INSTITUTE ON AGING University of Michigan At Ann Arbor United States 2024 – 2027

ABSTRACT Reversing the negative effects of aging has the potential to delay age-related diseases and significantly improve the quality of life in old age. In recent findings, we re...

$14.04M
USD
Active NON-SBIR/STTR RPGS
The Circadian Clock Coordinates Animal and Microbial Metabolism
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND K... Princeton University United States 2024 – 2027

Project Summary Our circadian clocks synchronize physiological processes and behaviors like eating and sleeping to environmental light cycles. The central clock located in the brai...

$14.58M
USD
Active NON-SBIR/STTR RPGS
Unraveling Fundamental Mechanisms of Interorgan Crosstalk in Osteoarthritis
NATIONAL INSTITUTE ON AGING University of California, San Francisco United States 2024 – 2027

PROJECT SUMMARY Osteoarthritis (OA), the loss of cartilage lining articular joints, is the leading cause of pain and disability worldwide. There are no existing treatments for OA a...

$14.76M
USD
Active NON-SBIR/STTR RPGS
Genomic recording systems to reveal evolutionary modifications in primate neocortex
NATIONAL INSTITUTE OF MENTAL HEALTH Princeton University United States 2024 – 2027

Project Summary/Abstract Primate brains develop following an exquisitely conserved Bauplan that is shared with other mammals, yet also possess advanced cognitive capabilities. Thes...

$13.9M
USD
Active NON-SBIR/STTR RPGS
Uncovering cellular and molecular adaptations for whole-organism rejuvenation
NATIONAL INSTITUTE ON AGING Baylor College of Medicine United States 2024 – 2027

PROJECT SUMMARY Organismal aging and age-associated diseases, including many cancers, are driven by the slow accumulation of damage in cells and tissues over time. In some instance...

$13.59M
USD
Completed SBIR-STTR RPGS
Translating a Novel Therapeutic Approach to the Treatment for Idiopathic Pulmonary Fibrosis
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE Vasarya Therapeutics, Inc United States 2024 – 2025

Project Abstract The goal of this Fast-Track SBIR application is to develop a novel drug candidate to treat Idiopathic pulmonary fibrosis (IPF). IPF is a fatal disease that remains...

$3.56M
USD
Completed SBIR-STTR RPGS
Cogito: A turnkey solution for rapidly developing, evaluating, deploying, and scaling digital therapeutics
NATIONAL INSTITUTE ON DRUG ABUSE Square2 Systems, Inc United States 2024 – 2025

Digital therapeutics are transforming healthcare. Digital therapeutics are clinical-grade software used to prevent, treat, or manage a medical disorder or disease. A large body of...

$2.96M
USD
Active NON-SBIR/STTR RPGS
A spatial view of hematopoietic regeneration dynamics in the bone marrow
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND K... University of Southern California United States 2024 – 2029

Project Summary: The regeneration of blood and immune cells relies on hematopoietic stem and progenitor cells (HSPCs) that reside in the bone marrow. HSPCs not only sustain homeost...

$16.31M
USD
Completed SBIR-STTR RPGS
Integration of an opioid dispensing, monitoring, and disposal platform with a hospital pharmacy to reduce opioid use by discharged emergency department patients
NATIONAL INSTITUTE ON DRUG ABUSE Addinex Technologies, Inc United States 2024 – 2025

SUMMARY The primary goal of this project is to integrate and assess the practicality of a closed-loop medication management system dispensed through a hospital-based pharmacy with...

$2.96M
USD
Completed SBIR-STTR RPGS
Therapy for Fecal Incontinence and FecalUrgency
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND K... Dignify Therapeutics, Llc United States 2024 – 2025

Fecal incontinence and fecal urgency (FI/FU) are extremely inconvenient and stigmatizing conditions that are common in the elderly, nursing home residents, women (due to anal damag...

$3.91M
USD
Active SBIR-STTR RPGS
A Novel Probiotic with The Potential for Long-term Management of Obesity and Insulin Resistance
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND K... Epic Nutrition for Y Llc United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT: Obesity is a major public health problem in the United States. It is linked to insulin resistance and type 2 diabetes, two devastating diseases that affec...

$1.94M
USD
Completed SBIR-STTR RPGS
Therapeutic Approach to Clear sdLDL from Circulation
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE Imetabolic Biopharma Corporation United States 2024 – 2025

Project Abstract Cardiovascular Disease (CVD) is a significant threat in the United States and developing countries across the globe. Widely associated with elevated low density li...

$3M
USD
Active NON-SBIR/STTR RPGS
A community-based adaptation of a peer-led intervention to address alcohol use and HIV risk in pregnant women in South Africa (Mentor Moms+)
NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM University of California Los Angeles United States 2024 – 2027

PROJECT SUMMARY The syndemic of alcohol use and HIV risk in pregnant and lactating people (PLP) threatens the health of mother, fetus, children and families in South Africa. PLP li...

$1.82M
USD
Completed SBIR-STTR RPGS
Decision Support System for Personalized Care of Ventilated Patients using Esophageal Pressure
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE Convergent Engineering, Inc United States 2024 – 2025

Project Summary Mechanical ventilation is an essential intervention for many patients but is associated with a risk of preventable complications and is a modifiable determinant of...

$2.96M
USD
Completed SBIR-STTR RPGS
Definitive (GLP) Toxicity and Toxicology Studies for a Novel Small Molecule for Protection Against Cardiotoxicity in Triple Negative Breast Cancer
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE Novomedix, Inc United States 2024 – 2025

Abstract The overall goal of this program is the development and commercialization of a novel, safe, and effective, therapy that synergizes with anthracyclines, such as Doxorubicin...

$5M
USD